Consensus Harmonic Inc.

Equities

HLIT

US4131601027

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
9.68 USD -3.10% Intraday chart for Harmonic Inc. -8.33% -25.77%

Evolution of the average Target Price on Harmonic Inc.

Price target over the last 5 years

History of analyst recommendation changes

d327c9b2e5400c6077710c3a.F2OM2OOW7i1G0oEF0YsTU0sYY5U7-FxtNEojZMfKST8.YRTG4aqhj3QBosdGmeBiHXpbUax2oTkrAgZzEq6sH1FgKvnrhfS-GX--zA~319009247706115cdfe84a9634159a19
Raymond James Trims Price Target on Harmonic to $18 From $19, Maintains Strong Buy Rating MT
Rosenblatt Securities Cuts Harmonic Price Target to $16 From $18, Maintains Buy Rating MT
Barclays Adjusts Price Target on Harmonic to $14 From $20, Maintains Overweight Rating MT
Raymond James Upgrades Harmonic to Strong Buy From Outperform, Adjusts Price Target to $16 From $15 MT
Jefferies Adjusts Harmonic Price Target to $18 From $19, Maintains Buy Rating MT
Raymond James Adjusts Price Target on Harmonic to $15 From $17, Maintains Outperform Rating MT
Rosenblatt Securities Adjusts Harmonic Price Target to $18 From $22, Maintains Buy Rating MT
Barclays Adjusts Harmonic's Price Target to $20 From $23, Keeps Overweight Rating MT
Needham Adjusts Harmonic's Price Target to $18 From $21, Keeps Buy Rating MT
Rosenblatt Adjusts Price Target on Harmonic to $22 From $20, Maintains Buy Rating MT
Barclays Adjusts Price Target on Harmonic to $23 From $20, Keeps Overweight Rating MT
Northland Securities Adjusts Price Target on Harmonic to $23 From $20, Keeps Outperform Rating MT
Raymond James Adjusts Harmonic Price Target to $17 From $18, Maintains Outperform Rating MT
Barclays Adjusts Harmonic's Price Target to $20 From $17, Keeps Overweight Rating MT
North American Morning Briefing : Stocks Seen Down as Rate Decisions Loom DJ
Needham Adjusts Price Target on Harmonic to $19 From $17, Maintains Buy Rating MT
Jefferies Upgrades Harmonic to Buy From Hold, Price Target is $19 MT
LifeSci Capital Downgrades Third Harmonic Bio to Market Perform From Outperform MT
Morgan Stanley Downgrades Third Harmonic Bio to Equalweight From Overweight, Slashes Price Target to $5 From $34 MT
Jefferies Downgrades Third Harmonic Bio to Hold From Buy, Slashes Price Target to $3.60 From $30 MT
Barclays Adjusts Price Target on Harmonic to $17 From $14, Keeps Overweight Rating MT
Raymond James Adjusts Price Target on Harmonic to $18 From $13, Maintains Outperform Rating MT
Rosenblatt Adjusts Price Target on Harmonic to $20 From $17, Maintains Buy Rating MT
Needham Adjusts Harmonic's Price Target to $17 From $15, Reiterates Buy Rating MT
Needham Adjusts Harmonic's Price Target to $15 from $14, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
9.99 USD
Average target price
15.67 USD
Spread / Average Target
+56.82%
High Price Target
18 USD
Spread / Highest target
+80.18%
Low Price Target
14 USD
Spread / Lowest Target
+40.14%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Harmonic Inc.

Raymond James
Rosenblatt Securities
Barclays
Jefferies & Co.
Needham & Co.
Northland Securities
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
  1. Stock Market
  2. Equities
  3. HLIT Stock
  4. Consensus Harmonic Inc.